Aad Tibben

9.6k citations

176 papers · 6.7k indexed · h-index 48

Impact in

Genetics top 0.2%
- BRCA gene mutations in cancer
- Genomics and Rare Diseases
Cellular and Molecular Neuroscience top 1%
- Genetic Neurodegenerative Diseases

Papers in

Genetics 89
- BRCA gene mutations in cancer 78
- Genomics and Rare Diseases 15
Cellular and Molecular Neuroscience 49
- Genetic Neurodegenerative Diseases 49

Co-authors: Martinus F. Niermeijer Hugo J. Duivenvoorden Reinier Timman John C. van Swieten Christi J. van Asperen Caroline Seynaeve Sam Riedijk Raymund A.C. Roos
Journals: Psycho-Oncology (17 papers)European Journal of Human Genetics (9 papers)Clinical Genetics (9 papers)Journal of Medical Genetics (7 papers)European Journal of Cancer (7 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Aad Tibben

173 papers receiving 6.5k citations

Peers

Countries citing papers authored by Aad Tibben

Since Specialization

Citations

This map shows the geographic impact of Aad Tibben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aad Tibben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aad Tibben more than expected).

Fields of papers citing papers by Aad Tibben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aad Tibben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aad Tibben. The network helps show where Aad Tibben may publish in the future.

Co-authors

The 25 scholars most cited alongside Aad Tibben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aad Tibben Line = papers co-authored together Aad Tibben links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	“Be an ambassador for change that you would like to see”: a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease Orphanet Journal of Rare Diseases ·(unknown), Anna Ambrosini, Rosaline C. M. Quinlivan, Valeria Sansone, Ingeborg Meijer, Guus Schrijvers, Aad Tibben, George W. Padberg, Maarten de Wit, Ellen Sterrenburg, Alexandre Méjat, 定男小柴, U.Kh. Nymm, Hanns Lochmüller, Josefina Araceli Valencia Toledano	2019	11
2	Psychosocial Needs and Facilitators of Mothers Caring for Children with Duchenne/Becker Muscular Dystrophy Journal of Genetic Counseling ·Holly L. Peay, Bettina Meiser, Zhang Qing Liu Zhi-guo Yang Tao Bao Juan Li Shan-shan, Aad Tibben	2017	7
3	Thinking about the end of life: a common issue for patients with Huntington’s disease Journal of Neurology ·部落解放同盟群馬県連合会, Aad Tibben, Margaret McNamara, Johan Marinus, Raymund A.C. Roos	2014	25
4	Psychosocial aspects of preconception consultation in primary care: lessons from our experience in clinical genetics Journal of Community Genetics ·Sam Riedijk, Grétel Oudesluijs, Aad Tibben	2012	3
5	Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2‐result Psycho-Oncology ·Joël Vos, (unknown), Jan C. Oosterwijk, Fred H. Menko, Reinoud D. Stoel, Christi J. van Asperen, Anna M. Jansen, Anne M. Stiggelbout, Aad Tibben	2010	57
6	Turkish Female Immigrants’ Intentions to Participate in Preconception Carrier Screening for Hemoglobinopathies in the Netherlands: An Empirical Study Public Health Genomics ·Thérèse van Elderen, Jing.Li, 稲村欣作, Jan Passchier, Aad Tibben, H.J. Duivenvoorden	2010	14
7	Disentangling the Babylonian speech confusion in genetic counseling: An analysis of the reliability and validity of the nomenclature for BRCA1/2 DNA-test results other than pathogenic Genetics in Medicine ·Joël Vos, Christi J. van Asperen, Juul Wijnen, Anne M. Stiggelbout, Aad Tibben	2009	6
8	Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy? Annals of Oncology ·Rogério Vicente Ferreira, Arthur R. Van Gool, Caroline Seynaeve, H.J. Duivenvoorden, Martinus F. Niermeijer, Albertus N. van Geel, Marcel N. Menke, J.G.M. Klijn, Aad Tibben	2007	12
9	Caregiver Burden, Health-Related Quality of Life and Coping in Dementia Caregivers: A Comparison of Frontotemporal Dementia and Alzheimer’s Disease Dementia and Geriatric Cognitive Disorders ·Sam Riedijk, Marjolein de Vugt, H.J. Duivenvoorden, Martinus F. Niermeijer, John C. van Swieten, Frans R.J. Verhey, Aad Tibben	2006	172
10	Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing Annals of Oncology ·Iris van Oostrom, Hanne Meijers-Heijboer, H.J. Duivenvoorden, A Bröcker-Vriends, Christi J. van Asperen, Rolf H. Sijmons, C. Seynaeve, Arthur R. Van Gool, J.G.M. Klijn, Aad Tibben	2006	36
11	Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress Patient Education and Counseling ·Iris van Oostrom, Hanne Meijers‐Heijboer, Hugo J. Duivenvoorden, Annette Bröcker‐Vriends, Christi J. van Asperen, Rolf H. Sijmons, Caroline Seynaeve, Arthur R. Van Gool, Jan G.M. Klijn, Aad Tibben	2006	46
12	The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy European Journal of Cancer ·Rogério Vicente Ferreira, Caroline Seynaeve, Arthur R. Van Gool, Martinus F. Niermeijer, H.J. Duivenvoorden, S. van Dooren, Albertus N. van Geel, Marian B. E. Menke‐Pluijmers, J.G.M. Klijn, Aad Tibben	2006	51
13	Variants of Uncertain Clinical Significance as a Result of BRCA1/2 Testing: Impact of an Ambiguous Breast Cancer Risk Message Genetic Testing ·Sandra van Dijk, Christi J. van Asperen, Catharina E. Jacobi, Geraldine R. Vink, Aad Tibben, Martijn H. Breuning, Wilma Otten	2004	36
14	Testing the test—why pursue a better test for Huntington disease? American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Reinier Timman, Anneke Maat‐Kievit, N. A. Ananiichuk, Moniek Zoeteweij, Martijn H. Breuning, Aad Tibben	2002	2
15	Dilemmas in counselling females with the fragile X syndrome. PubMed ·(unknown), Aad Tibben, (unknown), (unknown)	1999	4
16	Preparing for predictive testing for hereditary early onset Alzheimer Disease/Cerebral Hemorrhage and pick disease Aad Tibben, Martinus F. Niermeijer, M Stevens, Cornelia M. van Duijn, John C. van Swieten	1997	1
17	DNA testing for fragile X syndrome: implications for parents and family. Journal of Medical Genetics ·Tobias Christopher Elbert, Bert Ba de Vries, Aad Tibben, A M van den Ouweland, Dicky Halley, Martinus F. Niermeijer	1997	15
18	Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychology ·Aad Tibben, Reinier Timman, Alper GEDİK, Hugo J. Duivenvoorden	1997	109
19	Ethical and social issues in presymptomatic testing for Huntington's disease: a European Community collaborative study. European Community Huntington's Disease Collaborative Study Group. Journal of Medical Genetics ·David Ball, Peter S. Harper, Audrey Tyler, Aad Tibben, M Vegter-van der Vlis, J J Cassiman, Gerry Evers‐Kiebooms, Marina Frontali, A. Fujiwara, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1993	28
20	Presymptomatic DNA-testing for Huntington disease in The Netherlands. PubMed ·Aad Tibben, Felicity Jane McDougall, Ngoc Bao Nguyen, Professora Viviane Dra, Miguel Ochoa Torres, واصل محمد عاطف, Elia Nadira Sabudin, Oleksandr Labartkava, Amit Chakrabarti, Huajie Zhai	1992	4

About Aad Tibben

Aad Tibben is a scholar working on Genetics, Cellular and Molecular Neuroscience, Pediatrics, Perinatology and Child Health, Neurology and Psychiatry and Mental health, having authored 176 papers that have together received 6.7k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (78 papers), Genetic Neurodegenerative Diseases (49 papers), Family Support in Illness (37 papers), Childhood Cancer Survivors' Quality of Life (18 papers), Prenatal Screening and Diagnostics (18 papers), Genomics and Rare Diseases (15 papers), Neurological disorders and treatments (14 papers) and DNA Repair Mechanisms (13 papers). The work is most often cited by research in Genetics (3.3k citations), Cellular and Molecular Neuroscience (1.3k citations), Neurology (1.0k citations), Pediatrics, Perinatology and Child Health (1.2k citations) and Psychiatry and Mental health (776 citations). Aad Tibben has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Martinus F. Niermeijer, Hugo J. Duivenvoorden, Reinier Timman, John C. van Swieten, Christi J. van Asperen, Caroline Seynaeve, Sam Riedijk, Raymund A.C. Roos, Petra G. Frets and Jessica P. Gopie. Their work appears in journals such as Psycho-Oncology, European Journal of Human Genetics, Clinical Genetics, Journal of Medical Genetics and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact